Meanwhile, more than 15 percent received an ACE inhibitor plus an angiotensin-receptor blocker (ARB), a combination that evidence indicates is not very effective (Hypertension). In late 2011, the US Food and Drug Administration approved the first …
See all stories on this topic »
We LOVE you so.. how about liking us on Facebook?..
Powered By Facebook Like Post Plugin